Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways

Zoe Iliodromiti1, Dimitrios Zygouris, Stavros Sifakis

  • 12nd Department of Obstetrics and Gynecology, University of Athens Medical School, Aretaieio Hospital , Athens , Greece .

Insights

Acute lung injury (ALI) in preterm neonates is a serious condition caused by inflammation. Understanding these inflammatory pathways is key to developing new treatments for prevention and resolution.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Inflammation Research

Background:

  • Acute lung injury (ALI) significantly impacts preterm neonates, leading to high morbidity and mortality.
  • ALI involves damage to the fetal lung's alveolar-capillary unit and cellular linings due to inflammatory responses.
  • Key triggers include chorioamnionitis and mechanical ventilation, which induce proinflammatory cytokines.

Purpose of the Study:

  • To explore the inflammatory pathways linking intra-amniotic inflammation and ALI in preterm neonates.
  • To identify potential targets for novel interventional procedures.
  • To guide future research on ALI pathophysiology and pharmaceutical interventions.

Main Methods:

  • Review of existing literature on ALI pathogenesis in preterm neonates.
  • Analysis of inflammatory mediators (e.g., TNF-α, IL-1, IL-6, VEGF) involved in lung injury.
  • Examination of the role of chorioamnionitis, mechanical ventilation, and reactive oxygen species (ROS).

Main Results:

  • Inflammatory cytokines and products damage capillary endothelium and alveolar epithelium, causing hyaline membrane formation and alveolar edema.
  • Mechanical ventilation and hyperoxia-induced ROS contribute to ALI by increasing proinflammatory cytokines and tissue injury.
  • Chorioamnionitis is a major factor in initiating fetal lung inflammation.

Conclusions:

  • Understanding the inflammatory cascade connecting intra-amniotic inflammation and ALI is crucial for developing preventative strategies.
  • Further research into the pathophysiology of ALI and potential pharmaceutical interventions is warranted for preterm neonates.
  • Targeting inflammatory pathways offers a promising avenue for managing and treating ALI in this vulnerable population.